Introduction {#S1}
============

One major source of medicinally important small molecules are microbial BGCs that encode polyketide synthases (PKSs) and nonribosomal peptide synthetases (NRPSs), two classes of multi-functional mega-enzymes that are usually accompanied by sets of tailoring enzymes. The recent surge in the sequencing of fungal genomes has revealed large numbers of BGCs that do not appear to encode enzymes involved in the production of any known metabolites ("orphan BGCs") and thus may harbor new biosynthetic capabilities^[@R1]--[@R3]^.

In search of new biosynthetic mechanisms, we focused on orphan BGCs that contain small NRPS-*like* genes that diverge from canonical NRPSs in their domain structure. Canonical NRPSs include, at a minimum, one adenylation domain that selects and activates an amino acid (or related building block), one thiolation domain for covalent attachment of the activated amino acid, and a condensation domain that catalyzes formation of a peptide bond between the tethered amino acid and another substrate^[@R4]--[@R6]^. However, sequencing of fungal genomes has additionally revealed numerous genes that encode only a subset of these domains.^[@R1],[@R2]^ Such non-canonical, NRPS-like genes may feature adenylation and thiolation domains, but lack condensation domains, and thus likely do not function as peptide synthetases^[@R7],[@R8]^. We hypothesized that analysis of BGCs including small NRPS-like genes encoding incomplete modules would likely reveal novel biosynthetic functions.

Here we show that the *fsq* gene cluster in *A. fumigatus*, which features an NRPS-like gene, *fsqF*, produces a series of novel isoquinoline alkaloids, the fumisoquins. We then demonstrate that FsqF, which lacks a canonical condensation domain, is required for carbon-carbon bond formation between L-serine and L-tyrosine-derived building blocks in the fumisoquin biosynthetic pathway. Two additional enzymes encoded by the *fsq* cluster, the *N*-methyltransferase FsqC and the FAD-dependent oxidase FsqB, catalyze the formation of the isoquinoline ring system in the fumisoquins via a sequence that we show is directly analogous to the biosynthesis of a prominent group of plant isoquinoline alkaloids, one of the largest families of medicinally important natural products^[@R9],[@R10]^.

Results {#S2}
=======

*FsqF* encodes an incomplete NRPS module {#S3}
----------------------------------------

Expression of many fungal orphan BGCs is under the control of the nuclear protein LaeA, a global regulator of morphogenesis and virulence factor in *A. fumigatus* and other pathogenic fungi^[@R11],[@R12]^. Among LaeA-regulated orphan BGCs in the human pathogen *A. fumigatus*, the *fsq* cluster features a small NRPS-like gene, *fsqF*, which encodes an adenylation, thiolation, reductase and pyridoxal-phosphate dependent aminotransferase domain ([Fig. 1a](#F1){ref-type="fig"}). Notably, FsqF lacks the condensation domain that is essential for canonical peptide bond formation, and bioinformatic analysis of the vicinity of *fsqF* did not reveal any genes that could code for a second NRPS or free-standing condensation domain^[@R13]^. We found that expression of *fsqF* is regulated by the Zn(II)~2~Cys~6~-type transcriptional activator FsqA ([Fig. 1a](#F1){ref-type="fig"} and [Supplementary Results](#SD1){ref-type="supplementary-material"}, [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). Zn(II)~2~Cys~6~ transcription factors are unique to fungi and have been shown to regulate many metabolic pathways, e.g. aflatoxin biosynthesis in *A. flavus*^[@R14]^. In addition to *fsqF*, the transcription factor FsqA was found to regulate expression of five adjacent genes, annotated as ABC transporter (*fsqE*), fructosyl amino acid oxidase (*fsqB*), *N*-methyl-transferase (*fsqC*), phenol 2-monooxygenase (*fsqG*), and ATP-grasp enzyme (*fsqD*), defining the boundaries of the *fsq* cluster ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"})^[@R13]^.

Identification of *fsq* cluster-derived metabolites {#S4}
---------------------------------------------------

Overexpression of *fsqA* was associated with accumulation of a characteristic brown pigment in the surrounding media ([Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}), suggesting secretion of a colored metabolite(s). For the identification of *fsq*-derived metabolites we employed 2D NMR-based comparative metabolomics (differential analysis by 2D-NMR spectroscopy, DANS), which facilitates comprehensive and largely unbiased detection of new metabolites associated with gene cluster overexpression^[@R15],[@R16]^. DANS-based comparison of whole metabolome extracts from overexpression (OE::*fsqA*) and deletion (Δ*fsqA*) strains revealed several differential signals, most prominently two sets of OE-dependent doublets between 4.6 and 5.0 ppm with large coupling constants of 18--20 Hz ([Fig. 1b](#F1){ref-type="fig"}), suggesting a diastereotopic benzylic CH~2~ group within a bi- or oligocyclic structure. The OE::*fsqA*-dependent metabolites were characterized further following partial purification via reversed-phase chromatography, using a standard suite of 2D NMR spectra and high-resolution mass spectrometry (HRMS) ([Supplementary Table 1](#SD1){ref-type="supplementary-material"} and [Supplementary Note](#SD1){ref-type="supplementary-material"}). These analyses revealed two novel tricyclic isoquinoline derivatives, the pyrido\[1,2-*b*\]isoquinolines, fumisoquin A (**1**, [Fig. 1c](#F1){ref-type="fig"}) and fumisoquin B (**2,** [Fig. 1c](#F1){ref-type="fig"}) as major metabolites associated with *fsq*-overexpression. Fumisoquin A and B decompose gradually during chromatography, likely as a result of the oxidation-prone hydroquinone moiety. We further noted a deeply purple OE-dependent metabolite that was not captured by DANS because of decomposition during sample preparation. Optimization of extraction conditions and reverse-phase fractionation, followed by 2D NMR spectroscopic and HRMS analysis allowed to identify a third isoquinoline, fumisoquin C (**3**, [Fig 1c](#F1){ref-type="fig"}), as the deeply purple colored metabolite ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}, and [Supplementary Note](#SD1){ref-type="supplementary-material"}). Upon standing or during chromatography, fumisoquin C decomposes into compounds **4** and **5**, which are more stable and were isolated ([Fig. 1c](#F1){ref-type="fig"}, [Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}, and [Supplementary Note](#SD1){ref-type="supplementary-material"}). Treatment of partially purified fumisoquin C with (trimethylsilyl)diazomethane furnished the corresponding dimethyl derivative ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}), which is much less prone to decomposition and provided additional NMR spectroscopic data to confirm structure and relative configuration of fumisoquin C ([Supplementary Note](#SD1){ref-type="supplementary-material"}).

A plant-analogous isoquinoline formation pathway {#S5}
------------------------------------------------

Among known fungal natural products, isoquinoline alkaloids are rare, and the tricyclic ring systems of the fumisoquins, to the best of our knowledge, are unprecedented from fungi. However, the identified dihydroxylated isoquinolines are strikingly reminiscent of a large and diverse family of plant-derived isoquinoline alkaloids (pyrido\[1,2-*b*\]isoquinolines, e.g. scoulerine, **6**, [Fig. 1d](#F1){ref-type="fig"}), whose biosynthetic pathways have been studied extensively^[@R17]--[@R19]^. Plant pyrido\[1,2-*b*\]isoquinoline biosynthesis proceeds via *N*-methylation of a tyrosine-derived catechol precursor, followed by oxidative cyclization via the FAD-dependent berberine bridge enzyme (BBE, [Fig. 1d](#F1){ref-type="fig"})^[@R17]^, a member of a large group of flavin-dependent amine oxidases^[@R20],[@R21]^. The cyclization likely proceeds via a two-step mechanism, beginning with FAD-dependent oxidation of the methyl group to an iminium species followed by electrophilic attack on the deprotonated phenol, although earlier studies suggested an alternative, concerted mechanism^[@R17],[@R19]^. Because of the manifold pharmaceutical uses of plant isoquinoline alkaloids, there is considerable interest in developing microbial-based production approaches^[@R22]--[@R24]^, and yeast-based expression systems for several groups of plant isoquinoline alkaloids have been developed, including the berberines^[@R25]--[@R30]^. We noted that the *fsq* cluster features a set of genes that may encode functional analogs of the berberine biosynthetic enzymes, including the putative phenol 2-monooxygenase FsqG, *N*-methyltransferase FsqC, and FAD-dependent oxidase FsqB. Bioinformatic analysis revealed several orphan gene clusters in fungi that feature homologous sets of genes ([Supplementary Table 2](#SD1){ref-type="supplementary-material"} and [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). Moreover, the only other known fungal isoquinolines have been linked to a gene cluster containing homologs for these three genes^[@R31]^.

To investigate the biosynthesis of the fumisoquins, we created deletion strains in the OE::*fsqA* background for all genes in the *fsq* cluster, except for *fsqD* and the putative transporter *fsqE*, which we were unable to delete, which could be due to a protective function of these proteins as has been found in several other fungal BGCs^[@R1]^. We then compared the metabolomes of each of these deletion strains with those of OE::*fsqA* and Δ*fsqA* via DANS and HPLC-MS ([Fig. 2a--d](#F2){ref-type="fig"}). We found that deletion of the *N*-methyltransferase FsqC, phenol 2-monooxygenase FsqG, or FAD-dependent oxidase FsqB in OE::*fsqA* background led to complete abolishment of isoquinoline alkaloid production and accumulation of a series of benzyl pyrroles (**7--8**, [Fig. 2c](#F2){ref-type="fig"} and [Fig. 3](#F3){ref-type="fig"}), including the previously reported fumipyrrole, **7 (**where the *fsq* cluster was referred to as *fmp*^[@R32]^), smaller amounts of which were also produced in the OE::*fsqA* control strain ([Fig. 2c](#F2){ref-type="fig"}). Comparison of the carbon skeletons of the pyrroles **(7--8**, [Fig. 3](#F3){ref-type="fig"}) with those of the fumisoquins provided support for the predicted *N*-methyltransferase and phenol 2-monooxygenase functions of FsqC and FsqG, respectively, and suggested that the fumisoquins form from an open-chain precursor such as **9** ([Fig. 3](#F3){ref-type="fig"}), in a manner very similar to that of plant benzophenanthridine alkaloid biosynthesis^[@R18]^.

The structure of the putative open-chain precursor **9** suggested that it may be derived from tyrosine and a dehydroalanine equivalent (**10**, [Fig. 3](#F3){ref-type="fig"}), which could be produced from serine or cysteine via the pyridoxal-phosphate dependent aminotransferase domain of the NRPS-like protein FsqF^[@R10],[@R33]^. Growing the OE::*fsqA* strain in media supplemented with different stable-isotope labeled amino acids, we found that L-tyrosine and L-serine are incorporated into the fumisoquins and pyrroles (**1--3** and **8**) in a manner consistent with the biosynthetic model shown in [Fig. 3](#F3){ref-type="fig"}, whereas L-cysteine is not incorporated ([Fig. 4a,b](#F4){ref-type="fig"} and [Supplementary Fig. 6, 7b--d](#SD1){ref-type="supplementary-material"}, also see Online Methods). Furthermore, we showed that the L-methionine methyl group is incorporated into the fumisoquin ring systems at the predicted position, in agreement with the putative function of FsqC as an *S*-adenosyl methionine-dependent *N*-methyltransferase ([Fig. 4c](#F4){ref-type="fig"} and [Supplementary Fig. 8](#SD1){ref-type="supplementary-material"}).

FsqB is a functional analog of plant BBE {#S6}
----------------------------------------

To test whether FsqB catalyzes isoquinoline ring formation in **1--3** and thus acts as a functional ortholog of plant BBE, we recombinantly produced polyhistidine-tagged FsqB in *E. coli* ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). We then assayed its activity on a range of potential substrates that mimicked the tyrosine-derived portion of putative intermediate **9**. Whereas *N*-methyl dopamine did not react, we found that FsqB converts *N*-methyl DOPA **11**, prepared via a simple one-step procedure, directly into isoquinoline **12** ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Fig. 10, 12a](#SD1){ref-type="supplementary-material"}). We first tested FsqB activity on **11** on a small scale suitable for LCMS, which yielded near quantitative conversion to **12** within 3--4 h (100 mM phosphate buffer, pH 7, K~M~ = 142.5 ± 42.9 μM) ([Fig. 5b](#F5){ref-type="fig"}, [Supplementary Fig. 11](#SD1){ref-type="supplementary-material"}). Next we demonstrated isoquinoline formation from **11** on a milligram scale by conducting the reaction in an NMR tube using deuterated phosphate buffer ([Fig. 5c](#F5){ref-type="fig"} and [Supplementary Note](#SD1){ref-type="supplementary-material"}). Notably, FsqB-catalyzed formation of **12** proceeds with complete regioselectivity, as the alternative cyclization product, 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, **13**, which does form alongside **12** in a non-enzymatic reaction of DOPA with formaldehyde, was not observed ([Supplementary Fig. 10](#SD1){ref-type="supplementary-material"} and [Supplementary Note](#SD1){ref-type="supplementary-material"}). In contrast, we observed no cyclized products when incubating FsqB with *N*-methyl-L-tyrosine, *N,N*-dimethyl DOPA, or the BBE-substrate (*S*)-reticuline, suggesting that both a catechol moiety and a secondary β-*N*-methylamine are required for FsqB activity ([Supplementary Fig. 12b--d](#SD1){ref-type="supplementary-material"}).

Next we asked whether the mechanism of isoquinoline formation as catalyzed by FsqB is directly analogous to that of the extensively studied plant enzyme, BBE^[@R9],[@R17],[@R19],[@R34]^. Fluorescence analysis of recombinant FsqB showed excitation and emission maxima at 461 nm and 530 nm, respectively ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}), suggesting FsqB utilized a flavin cofactor, as predicted^[@R35]^. Further proteomic analysis of FsqB confirmed the presence of FAD, which was found to be covalently bound to cysteine-414 ([Supplementary Fig. 13a](#SD1){ref-type="supplementary-material"} and [Supplementary Table 3](#SD1){ref-type="supplementary-material"}). FAD is also part of BBE where it is bound to a histidine residue^[@R17]^. Flavin reduction during catalytic cycling of BBE is recovered with molecular oxygen generating hydrogen peroxide^[@R17]^, a characteristic that was also observed with FsqB utilizing an Amplex Red assay ([Supplementary Fig. 13b](#SD1){ref-type="supplementary-material"}). Isoquinoline formation as catalyzed by BBE likely proceeds via an imine intermediate in a two-step mechanism^[@R19]^. To test whether isoquinoline formation via FsqB also involves an imine intermediate, we incubated FsqB with *N*-methyl-L-tyrosine **14**, which we hypothesized may represent an oxidation-competent substrate for FsqB but, as shown above, does not get cyclized, in the presence of the electrophile trapping agent dimedone, **15**. This reaction produced the adduct **16** as well as free tyrosine, consistent with capture of an imine intermediate, **17**, by dimedone or water ([Fig. 5d](#F5){ref-type="fig"}). Therefore, it appears that the fungal enzyme FsqB catalyzes isoquinoline formation via a two-step mechanism that is analogous to that of plant-derived BBE.

Carbon-carbon bond formation requires FsqF {#S7}
------------------------------------------

Next we recombinantly produced the FsqF adenylation domain to test whether it activates L-tyrosine or L-serine, as suggested by the stable isotope labeling study, using the ATP-\[^32^P\]pyrophosphate exchange activity^[@R36]^. However, neither enantiomer of serine or tyrosine showed any activity in the *in vitro* assay nor did any other tested standard amino acid ([Supplementary Fig. 14](#SD1){ref-type="supplementary-material"}). These results may indicate that the recombinantly expressed FsqF adenylation domain was not functional or that the true substrate is not a standard amino acid. Based on the homology of the PLP-dependent domain in FsqF to other serine dehydrogenases^[@R13],[@R33]^, we hypothesized that L-serine may first be converted into dehydroalanine, which is then activated and tethered to the thiolation domain ([Fig. 3](#F3){ref-type="fig"}).

To further investigate the role of the NRPS-like enzyme FsqF in fumisoquin biosynthesis, we analyzed the effect of *fsqF* deletion on the OE::*fsqA* metabolome. As anticipated, production of the fumisoquins (**1--3**) as well as the pyrroles (**7--8**) was completely abolished in OE::*fsqA-*Δ*fsqF* ([Fig. 2d](#F2){ref-type="fig"}). Significantly, we also observed production of a single, brightly red shunt metabolite, the anthranilic acid-substituted isoquinoline **18** ([Fig. 2d](#F2){ref-type="fig"} and [Fig. 3](#F3){ref-type="fig"}). Feeding experiments of the OE::*fsqA-*Δ*fsqF* mutant with stable-isotope labeled L-tyrosine confirmed that the isoquinoline ring system in **18** is derived from tyrosine, as in the case of the fumisoquins ([Supplementary Fig. 15](#SD1){ref-type="supplementary-material"}). Incubation of **12**, obtained *in vitro* from recombinant FsqB, with anthranilic acid (**19**) led to formation of shunt metabolite **18**, consistent with a model in which shunt metabolite **18** forms non-enzymatically from **12** via oxidation to the corresponding *o*-quinone, subsequent capture of anthranilic acid, and decarboxylation ([Supplementary Fig. 16](#SD1){ref-type="supplementary-material"}). Compound **12** was not observed in any of the analyzed OE::*fsqA-*Δ*fsqF* extracts, likely as a result of this compound's high susceptibility to oxidize to the reactive *o*-quinone, which is rapidly captured by anthranilic acid ([Supplementary Fig. 16](#SD1){ref-type="supplementary-material"}).

The identification of shunt metabolite **18** indicates that the NRPS-like protein FsqF is only required for addition of a serine-derived dehydroalanine moiety to activated tyrosine, but is not essential for the subsequent steps leading to isoquinoline formation, and that a different enzyme, likely the ATP-grasp enzyme FsqD, is responsible for activation of tyrosine ([Fig. 3](#F3){ref-type="fig"}). The production of shunt metabolite **7** would then indicate that FsqD is also capable of activating phenylalanine; however, phenylalanine-derived intermediates only lead to the production of **7**, as expected based on the predicted function of FsqG as a phenol 2-monooxygenase^[@R13]^ and given the observation that recombinantly produced FsqB requires a catechol as substrate. FsqD has homology to carboxylate-amine ligases that furnish aminoacyl phosphate from ATP and amino acid precursors^[@R37],[@R38]^. In a recent example, the FsqD homolog PGM1 was shown to activate non-proteinogenic amino acids for peptide-bond formation in pheganomycin biosynthesis^[@R39]^. In contrast, FsqD appears to activate tyrosine (or phenylalanine) for subsequent condensation with serine-derived dehydroalanine ([Fig. 3](#F3){ref-type="fig"}), providing a first example for a novel carbon-carbon bond forming strategy in fungi.

Discussion {#S8}
==========

Our analysis of the *fsq* cluster revealed a plant-like strategy for the biosynthesis of oligocyclic alkaloids in fungi. The biosynthetic steps of phenol-hydroxylation, *N*-methylation, and oxidative cyclization appears to be the same in plants and fungi, and thus the corresponding enzymes can be considered functionally equivalent. Sequence analysis does not suggest homology for these proteins, though it is notable that cyclization proceeds via analogous two-step mechanisms that are catalyzed by FAD-dependent oxidases in both fungi and plants^[@R19]^, presenting a striking case of convergent evolution of specialized metabolic pathways. Given that analysis of available fungal genomes^[@R13]^ revealed many co-occurrences of homologs of the *N*-methyltransferase *fsqC* and FAD-dependent oxidase *fsqB* ([Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}), it seems likely that fungi are capable of producing a diverse range of yet undiscovered isoquinoline alkaloids. For example, in addition to *Aspergillus* spp., the genomes of plant pathogenic *Fusarium* spp. feature BGCs that include homologues for most *fsq* genes^[@R40]^.

Together with other recent examples^[@R7],[@R8]^, the identification of the fumisoquins shows that analysis of gene clusters containing incomplete NRPS modules can reveal intriguing new structures and biosynthetic strategies. It remains unclear, however, whether the biosynthetic roles of NRPS-like enzymes can be predicted, as current examples, though few, hint at considerable functional diversity. For example, two NRPS-like enzymes in *A. flavus*, named LnaA and LnaB, have been shown to produce a series of tyrosine-derived piperazines, pyridines and morpholines^[@R7]^, whereas an NRPS-like enzyme from *A. terreus* was shown to reduce products of an accompanying non-reducing PKS^[@R8]^. The example of the *fsq* pathway demonstrates that NRPS-like enzymes lacking condensation domains may nonetheless contribute to ligating amino acids, albeit via formation of carbon-carbon bonds. Characterization of BGCs featuring small NRPS-like genes may thus reveal new types of alliances of NRPS-like enzymes with other amino acid-activating proteins, e.g. ATP-grasp enzymes such as FsqD.

This work supports a mining strategy of assessing fungal natural products, beyond not only canonical NRPS but also PKS-like genes and even those fungal clusters lacking NRPS or PKS-like domain genes all together. Recent examples have focused on cyclic ribosomal peptides^[@R41]^ but a bioinformatic scan of fungal genomes and expression data shows the existence of yet more alternative biosynthetic clusters -- lacking NRPS-like, PKS-like and canonical ribosomal peptides - suggestive of unexplored chemical diversity^[@R42]^. Efforts to characterize such alternative clusters may yield even more unique fungal chemistry.

Online Methods {#S9}
==============

Strains, media, and growth conditions {#S10}
-------------------------------------

The fungal strains used in this study are listed in [Supplementary Table 4](#SD1){ref-type="supplementary-material"}. All strains were grown at 37 °C on glucose minimal medium (GMM)^[@R43]^ and, when appropriate, were supplemented with 0.56 g/L uracil, 1.26 g/L uridine, 1.0 g/L arginine and maintained as glycerol stocks at −80 °C. *Escherichia coli* strain DH5α was propagated in LB medium with appropriate antibiotics for plasmid DNA.

Gene cloning, plasmid construction, and genetic manipulations {#S11}
-------------------------------------------------------------

The plasmids utilized in this study are listed in [Supplementary Table 4](#SD1){ref-type="supplementary-material"}. The oligonucleotide sequences for PCR primers are given in [Supplementary Table 5](#SD1){ref-type="supplementary-material"}. PCR amplification was carried out on a C1000^TM^ Thermal Cycler (Bio-Rad). For creation of the *fsqA* overexpression (OE) strain (TJES1.18) the OE cassette was constructed by amplifying the *fsqA* open reading frame (ORF) from *Af293* genomic DNA using primers Afu6g03430_NcoI_For and Afu6g03430_NotI_Rev, which introduced a 5′ NcoI restriction site and a 3′ NotI restriction site. This PCR product was purified with a QIAquick gel extraction kit (Qiagen), quantified, and digested with the appropriate restriction enzymes before being cloned into pJMP8.12^[@R44]^, resulting in plasmid pJES 1.2. Subsequently, *A. fumigatus argB* was transferred from pJMP4.1^[@R45]^ by digesting with EcoRI and introduced into pJES1.2, resulting in plasmid pJES2.7 (*A. fumigatus argB::gpdA(p)::fsqA*). All PCR steps were carried out with Pfu Ultra II DNA Polymerases (Agilent) and all digestion reactions were carried out with NEB enzymes (New England BioLabs). Correctness of the inserted DNA was then confirmed by sequencing.

Construction of the *fsq* gene knock-out cassettes were generated using standard double-joint PCR procedures^[@R46]^. Briefly, *A. parasiticus pyrG* (*A.ppyrG)* was amplified from pJMP9.1. Then, an approximately 1 kb fragment upstream and downstream of each *fsq* gene was amplified from genomic DNA of *A. fumigatus* Af293 using designated primers, respectively. These three amplified PCR products were purified with a QIAquick gel extraction kit, quantified, and fused using standard double-joint PCR procedures. The final PCR product was amplified with the bottom primer pairs, *gene*\_5′F_flank and *\_*3′R_flank, confirmed with endonuclease digestion, and purified for fungal transformation. The first two rounds of PCR were done with Pfu Ultra II DNA Polymerases (Agilent), and the final PCR step used Expand long template PCR system (Roche) according to the manufacturer's instructions. Af293.6 (double auxotroph *A. fumigatus, pyrG^−^, argB^−^*) was used to make the *OE::fsqA, pyrG^−^* auxotroph, TJES1.18. This strain was used as the recipient host strain for subsequent deletions of *fsq* genes as well as the ectopic complementation of *pyrG1* with plasmid pJMP9.1 (containing *A.ppyrG*) resulting in prototrophic strain TJES3.1 (OE::*fsqA, A.ppyrG*). Similarly Δ*fsqA* auxotrophic strains (TJES2.20) were made by transforming Af293.6 with deletion cassettes and complemented with ectopically integrated pJMP4 to make Δ*fsqA* prototroph TJES8.2.

For the creation of deletion mutants in OE*::fsqA* TJES1.18 background, a deletion cassette of each cluster gene (*fsqB* to *fsqG*) was constructed by using double-joint PCR with *A. parasiticus pyrG* (*A.ppyrG*) for replacement of target genes. The *A.ppyrG* gene was amplified from the plasmid pJMP9.1 as template. Five μg of the double-joint PCR cassette were used to delete each *fsq* cluster gene by using TJES1.18 (*A.fargB::gpdA(p):: fsqA, pyrG1*) as the recipient host. After transformation, transformants were grown on minimal media plates without supplements for screening. All strains were verified by PCR and Southern blot analysis ([Supplementary Fig. 17](#SD1){ref-type="supplementary-material"}. Multiple confirmed strains for each mutant were stored at −80 °C with 33 % glycerol for future use.

Heterologous protein production and biochemical assays {#S12}
------------------------------------------------------

The expression vectors for the *fsqF* (NRPS-like) adenylation domain (pJES13.2) were constructed by amplifying bases 1-1968 of the coding DNA sequence (CDS) of the gene Afu6g03480 from Af293 using primers fqsF_Adomain_xp_5′F and fqsF_Adomain_xp_3′R introducing 5′ NotI and 3′ XhoI restriction sites, respectively. These products were gel purified and digested with the appropriate enzymes before being cloned into pET30-a(+) (EMD Biosciences) to create an expression plasmid with a 6xHis tagged *fsqF* adenylation domain. The plasmid was introduced into chemically competent *E.coli* DH5α, selected on LB agar with Kanamycin and confirmed by sequencing. Subsequently, they were extracted from DH5α cells and used to transform expression host *E.coli* BL21. Protein purification was carried out as described^[@R47]^. All reactions were carried out in triplicate. Reaction parameters for the ATP-\[^32^P\]pyrophosphate exchange assay were: total assay volume of 100 μL at 25°C in 100 mM phosphate buffer, 5 mM MgCl~2~, 125 nM EDTA, 5 mM ATP, 100 nM purified FsqF adenylation domain, 0.1 μM \[^32^P\]pyrophosphate (50 Ci/mmol), and 1 mM amino acid substrate. The reaction proceeded for 30 min before it was stopped (1 % (w/v) activated charcoal, 4.5 % (w/v) tetrasodium pyrophosphate, 3.5 % (v/v) perchloric acid) and further processed as described^[@R48]^. Pyrophosphate exchange was quantified on a scintillation counter (PerkinElmer TriCarb 2910TR).

The expression vector for *fsqB* (fructosyl amino acid oxidase) was constructed using the CDS of the gene Afu6g03440 from OE::*fsqA* using primers pet28_fsqB_3′\_fwd and fsqB_5′\_pet28_rev. These products were gel purified and cloned into pET28-b(+) using ligase-free PCR cloning to create an expression plasmid with a 6xHis tagged FsqB. The plasmid was introduced into chemically competent *E. coli* DH5α, selected on LB agar with Kanamycin and confirmed by sequencing. Subsequently, they were extracted from DH5α cells and used to transform expression host *E. coli* BL21(DE3) (New England BioLabs). BL21(DE3) pET28-b(+) *fsqB* containing *E. coli* were grown in LB containing 50 μg/mL Kanamycin at 37 °C to an OD of \~0.6, cooled to 18 °C and expression was induced with 250 μM IPTG for 15 hrs. 4 L of LB containing *E. coli* were harvested at 6000 G for 20 min yielding 10.6 g of wet weight pellet and stored at −80 °C. Protein purification was carried out at 4 °C by resuspending the pellet in lysis buffer containing 100 mM phosphate buffer pH 7.8, 10 mM imidazole, 10 % (v/v) glycerol, 1 mM PMSF, 0.1 mg/mL lysozyme, 0.1 mg/mL Benzonase (EMD Millipore) and sonicated. All following steps were performed in low light to avoid detrimental flavin mediated reactions. Lysed cells were centrifuged at 20000 G for 20 min, and loaded onto TALON affinity resin (Clontech) pre-equilibrated with lysis buffer and incubated for 30 min with stirring. Resin was loaded onto a column and washed with 2 column volumes of lysis buffer without lysosome or Benzonase. FsqB was eluted with 100 mM phosphate buffer pH 7.8, 150 mM imidazole, 10 % (v/v) glycerol with 8 column volumes, concentrated and buffer exhanged with Amicon Ultra-15 centrifugal filter 30 kDa cutoff with 100 mM phosphate buffer pH 7.8, 25 % (v/v) glycerol and stored at −80°C. Activity assays were performed in total assay volumes of 100 μL at 37 °C in 100 mM phosphate buffer pH 7.0 in the dark. Reaction products were identified on a Thermo Scientific-Dionex Ultimate3000 UHPLC system equipped with a diode array detector and connected to a Thermo Scientific Q Exactive Orbitrap operated in electrospray negative (ESI-) ionization mode. UV-Vis absorbance spectra were obtained on a Cary 5000 UV-Vis-NIR spectrophotometer, and fluorescence emission was obtained on a HORIBA Nanolog Spectrofluorometer.

FsqB Steady-state kinetic analysis and imine capture {#S13}
----------------------------------------------------

Steady-state kinetics were carried out at 25 °C in 100 mM phosphate buffer pH 7.0 with 100 nM FsqB at final volumes of 500 or 1000 μL at various initial concentrations of *N*-methyl-3,4-dihydroxy-DL-phenylalanine (**11**). Imine capture was carried out at 25 °C in 100 mM phosphate buffer pH 7.0 with 1.5 μM FsqB, 400 μM *N*-methyl-L-tyrosine (**14**), and 1 mM dimedone (**15**) (Sigma Aldrich) with \<0.5% (v/v) methanol for dimedone solubility. Both kinetics and imine capture were monitored with low-resolution HPLC-MS performed on an Agilent 1100 series HPLC system equipped with a diode array detector and connected to a Quattro II mass spectrometer (Micromass/Waters) operated in electrospray negative ionization (ESI^−^) mode for kinetic analysis and positive electrospray ionization (ESI^+^) mode for imine capture. Kinetic data analysis was performed using GraphPad Prism version 6.00 for Windows (GraphPad Software).

FsqB Amplex Red assay {#S14}
---------------------

100 μM *N*-methyl-DL-DOPA or DL-DOPA, either with or without 15 μM FsqB, were incubated in 100 mM pH 7.0 potassium phosphate buffer at 25 °C in 100 μL total reaction volume in the dark in a 96-well plate with gentle shaking. After 1.5 h of incubation, 100 μL of hydrogen peroxide detection mixture (containing 50 mM potassium phosphate pH 7.0, 100 μM Amplex Red (Thermo Scientific), 0.2 units/mL HRP) was added and incubated at 25 °C in the dark for 10 minutes. Readings were performed on a BioTek Synergy 2 96-well plate reader using a 500±27 nm excitation filter and a 615±15 nm emission filter and normalized to 0 and 100 μM hydrogen peroxide standards. All conditions were performed in triplicate.

FsqB trypsinization analysis {#S15}
----------------------------

80 μg of recombinant FsqB was buffer exchanged into 55 μL of 50 mM ammonium bicarbonate. 3 μL of 0.33 μg/μL of sequencing grade porcine trypsin (Promega) was added to FsqB and incubated at 37 °C for 12 h. 5 μL 50 mM TCEP was added and the mixture was further incubated at 37 °C for 10 min. The solution was cooled to 25 °C and 5 uL of 100 mM iodoacetamide was added and incubated at 25 °C in the dark for 1 h. Formic acid was added to 1 % (v/v), and peptides were prepared with 100 μL Pierce C~18~ Tips (Thermo Scientific) per manufacturers protocol utilizing 100 μL elution solution. Peptides were identified via UHPLC-MS/MS using a Thermo Scientific Dionex Ultimate 3000 UHPLC system equipped with a diode array detector and connected to a Thermo Scientific Q Exactive Orbitrap operated in positive electrospray (ESI^+^) ionization mode.

Nucleic acid analysis {#S16}
---------------------

Preparation of plasmids, restriction enzyme digestions, gel electrophoresis, blotting, probe preparation and hybridization were carried out by standard protocols. *Aspergillus* DNA was extracted using a previously described method^[@R49]^. Sequence data were analyzed using the LASERGENE software package from DNASTAR.

Northern analysis {#S17}
-----------------

50 mL of liquid GMM^[@R43]^ were inoculated with 1.0×10^6^ spores (asexual) mL^−1^ of all appropriate strains in this study and incubated with shaking at 250 rpm at 25 °C. After 48 h, the mycelium was collected and total RNA was extracted by using Isol-RNA Lysis Reagent according to the manufacturer's instructions (5 Prime).

In order to determine the boundaries of the *fsq* gene cluster, gene fragments of potential cluster genes used as probes were amplified individually from Af293 genomic DNA with appropriate primers. WT, OE::*fsqA* (TJES3.1)*,* and Δ*fsqA* (TJES8.2) were used for this experiment. About 40 μg of total RNA were used for RNA blot analysis. RNA blots were hybridized with designated DNA fragments. All experiments were performed in duplicate. Detection of signals was carried out with a Storm 860 phosphoimager (Molecular Dynamics).

Fermentation and metabolome extraction for comparative metabolomics by DANS and HPLC-UV-MS {#S18}
------------------------------------------------------------------------------------------

Preparation for NMR spectroscopic analysis: *A. fumigatus* strains were inoculated (1.0×10^6^ spores mL^−1^) into 1 L GMM^[@R43]^ in a 2 L Erlenmeyer flask at 37 °C with shaking at 220 rpm. After 4 days, liquid fungal cultures including fungal tissue and media were frozen using a dry ice acetone bath, and lyophilized. The lyophilized residues were extracted with 500 mL of 10 % methanol in ethyl acetate for 3.5 h with vigorous stirring. Extracts were filtered over cotton, evaporated to dryness, and stored in 8 mL glass vials at −20 °C. Prior to NMR spectroscopic analysis, the crude extracts (\~30--50 mg) were suspended in 0.15 mL of methanol-*d~4~*. The resulting suspension was evaporated to dryness, the residue re-suspended in 0.6 mL of methanol-*d~4~*, centrifuged to remove insoluble materials, and the supernatant was transferred into a 5 mm NMR tube.

Preparation for HPLC-MS analysis: *A. fumigatus* strains were inoculated (1.0×10^6^ spores mL^−1^) into 50 mL GMM^[@R43]^ in a 125 mL Erlenmeyer flask at 37 °C with shaking at 220 rpm. After 4 days, liquid fungal cultures including fungal tissue and media were frozen using a dry ice acetone bath, and lyophilized. The lyophilized residues were extracted with 30 mL of MeOH for 1.5 h with vigorous stirring. Extracts were filtered over cotton, evaporated to dryness, and stored in 4 mL vials. Crude extracts were suspended in 0.5 mL of MeOH and centrifuged to remove insoluble materials, and the supernatant was subjected to HPLC-MS analysis.

Fermentation and metabolome extraction for compounds 3--5 {#S19}
---------------------------------------------------------

*A. fumigatus* strains were inoculated (1.0×10^6^ spores mL^−1^) into 1 L GMM^[@R43]^ in a 2 L Erlenmeyer flask at 37 °C with shaking at 220 rpm. After 3.5 days, liquid fungal cultures including fungal tissue and media were frozen using a dry ice acetone bath, and lyophilized. The lyophilized residues were extracted with 500 mL of MeOH for 1 h with vigorous stirring. Extracts were filtered over cotton and evaporated on Celite-545 (Acros Organics) to dryness. The dry Celite was then loaded into a 25 gram solid phase cartridge (Isco) and subjected to large-scale reverse phase chromatography (see Chromatographic enrichment section below for details). Compounds **4** and **5** are also minor components of the culture media.

Analytical methods and equipment overview {#S20}
-----------------------------------------

\(a\) NMR spectroscopy: NMR spectroscopic instrumentation: a Varian INOVA 600 MHz NMR spectrometer (600 MHz ^1^H reference frequency, 151 MHz for ^13^C) equipped with an HCN indirect-detection probe or a Bruker Avance^III^ HD (800 MHz ^1^H reference frequency, 201 MHz for ^13^C) equipped with a 5 mm CPTCL ^1^H-^13^C/^15^N cryo probe. Non-gradient phase-cycled dqfCOSY spectra were acquired using the following parameters: 0.6 s acquisition time, 400--600 complex increments, 8, 16 or 32 scans per increment. Non-gradient HSQC, HMQC, and HMBC spectra were acquired with these parameters: 0.25 s acquisition time, 200--500 increments, 8--64 scans per increment. ^1^H, ^13^C-HMBC spectra were optimized for J~H,C~ = 6 Hz. HSQC spectra were acquired with or without decoupling. Susceptibility-matched NMR tubes (Shigemi) were used for sample amounts smaller than 1 mg. NMR spectra were processed and baseline corrected using MestreLabs MNOVA software packages. (b) Mass spectrometry: high-resolution UHPLC-MS was performed on a Thermo Scientific-Dionex Ultimate3000 UHPLC system equipped with a diode array detector and connected to a Thermo Scientific Q Exactive Orbitrap operated in electrospray positive (ESI^+^) or electrospray negative (ESI^−^) ionization mode. Low-resolution HPLC-MS was performed on an Agilent 1100 series HPLC system equipped with a diode array detector and connected to a Quattro II mass spectrometer (Micromass/Waters) operated in ESI^+^ or ESI^−^ mode. Data acquisition and processing for the LC-HRMS was controlled by Thermo Scientific Xcalibur software. Data acquisition and processing for the HPLC-MS was controlled by Waters MassLynx software. (c) Chromatography: flash chromatography was performed using a Teledyne ISCO CombiFlash system. For semi-preparative HPLC Agilent Zorbax Eclipse XDB-C18 or -C8 columns (25 cm × 10 mm, 5 μm particle diameter) were used. An Agilent Zorbax RRHD Eclipse XDB-C18 column (2.1 × 100 mm, 1.8 μm particle diameter) was used in the LC-HRMS *A. fumigatus* mutant profiling analysis. An Agilent Zorbax Eclipse XDB-C18 column (4.6 × 250 mm, 5 μm particle diameter) was used in the HPLC-MS *A. fumigatus* mutant profiling analysis.

Chromatographic enrichment of compounds 1, 3, dimethyl-3, 7--8, 11--13, and 18 {#S21}
------------------------------------------------------------------------------

Methanol extracts derived from 1--2 L of *A. fumigatus* cultures were fractionated using large-scale reverse-phase flash chromatography on a Teledyne ISCO CombiFlash with a Teledyne C18 gold (100 gram) column with acetonitrile (organic phase) and 0.1 % acetic acid in water (aqueous phase) as solvents at a flow rate of 60 mL/min. A linear ramp from 0 % organic to 100 % organic over 30 min was used and fractions containing compounds of interest were collected, evaporated to dryness, and stored in 8 mL glass vials at −20 °C. Fractions containing compounds **1**, **3**, dimethyl-**3**, **7--**8, **11--13,** and **18** were further purified via semi-preparative HPLC using an Agilent XDB C-18 or C-8 column (25 cm × 10 mm, 5 μm particle diameter) acetonitrile (organic phase) and 0.1 % acetic acid in water (aqueous phase) as solvents at a flow rate of 3.6 mL/min. A solvent gradient scheme was used, starting at 5 % organic for 3 min, followed by a linear increase to 100 % organic over 27 min, holding at 100 % organic for 5 min, then decreasing back to 5 % organic for 0.1 min, and holding at 5 % organic for the final 4.9 min, for a total of 40 min.

*In vivo* stable isotope labeling experiments {#S22}
---------------------------------------------

Deuterium- and ^13^C-labeled amino acids were purchased from Cambridge Isotopes Inc. Each amino acid (labeled or unlabeled control) was added to 50 mL (2 mM) of GMM^[@R43]^ media in 125 mL Erlenmeyer flasks. Each flask was inoculated with OE::*fsqA* or OE::*fsqA*-Δ*fsqF* (1.0 × 10^6^ spores mL^−1^) and grown for 4 days at 37 °C with shaking at 220 rpm. After 4 days, liquid fungal cultures including fungal tissue and media were frozen using a dry ice acetone bath and lyophilized. The lyophilized residues were extracted with MeOH (25 mL) for 1.5 h with vigorous stirring. Extracts were filtered over cotton, evaporated to dryness, and stored in 4 mL vials at −20 °C. Crude extracts were suspended in 0.5 mL of MeOH and centrifuged to remove insoluble materials, and the supernatant was subjected to HPLC-MS analysis.

Conversion of 3 into dimethyl-3 for NMR spectroscopic analysis {#S23}
--------------------------------------------------------------

To a solution of a partially purified fumisoquin C (**3**) in 3:2 toluene/MeOH (2 mL) was added (trimethylsilyl)diazomethane (Sigma-Aldrich) (20 μL, 0.04 mmol) as a 2.0 M diethyl ether solution. After stirring at room temperature for 30 min, the mixture was quenched with glacial acetic acid (10 μL) and dried by rotary evaporation. The mixture was resuspended in MeOH (100 μL) and dimethyl-**3** was purified by semi-preparative HPLC (see section "chromatographic enrichment" above for details).

Synthesis of FsqB substrates {#S24}
----------------------------

All reagents were purchased and used as is from Sigma-Aldrich. All solvents were purchased and used as is from Fischer Scientific. *N*-methyl-3,4-dihydroxy-DL-phenylalanine (**11**). A 100 mL Schlenk flask under argon at room temperature was charged with 3,4-dihydroxy-DL-tyrosine (394 mg, 2.0 mmol), dissolved in 50 mL of a 7:3 mixture of water and MeOH. To this NaBH~4~ (228 mg, 6.6 mmol) was added, followed by immediate addition of formaldehyde (0.5 mL of a 37 % solution in H~2~O, 6.0 mmol). The reaction was stirred for 1 h at room temperature then quenched by addition of glacial acetic acid (10 mL). The solvents were removed by rotary evaporation, and the product isolated by reverse-phase HPLC. See [Supplementary Note](#SD1){ref-type="supplementary-material"} for full NMR spectroscopic data of (**12**). *N*-methyl-dopamine. This compound was prepared according to the literature procedure^[@R50]^.
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![Analysis of the *fsq* gene cluster and metabolite production\
(**a**) *fsq* gene cluster and putative assignments of encoded proteins. TF: transcription factor; FAD: FAD-binding domain protein; MT: *N*-methyltransferase; D-ala: ATP-grasp enzyme (D-alanine ligase); Trs: transporter; NRPS: nonribosomal peptide synthetase (A = adenylation, T = thiolation, R = short-chain dehydrogenase/reductase domain, P: pyridoxal phosphate binding domain); MO: phenol 2-monooxygenase. (**b**) Section of the dqfCOSY spectra of OE::*fsqA* and Δ*fsqA* metabolite extracts used for comparative metabolomics (DANS). (**c**) Identified *fsq*-dependent compounds fumisoquin A and B (**1** and **2**), including stereochemical assignments via NOESY for **1** (see [Supplementary Note](#SD1){ref-type="supplementary-material"}), as well as structure of fumisoquin C (**3**), which decomposes to **4** and **5**. (**d**) Biosynthesis of structurally related isoquinoline alkaloids in plants via coclaurine *N*-methyltransferase (CNMT), *N*-methylcoclaurine 3′-monooxygenase (CYP80B), 3′-hydroxy-*N*-methyl-(*S*)-coclaurine 4′-*O*-methyltransferase (4′OMT) and berberine bridge enzyme (BBE).](nihms762624f1){#F1}

![Comparative metabolomics of *fsq* gene cluster mutants by HPLC-MS\
(**a--d**) HPLC-MS analysis of *fsq*-gene deletion strains in OE::*fsqA* background, shows ion chromatograms representing major products and shunt metabolites.](nihms762624f2){#F2}

![Model for fumisoquin biosynthesis\
(A = adenylation, T = thiolation, R = short-chain dehydrogenase/reductase domain, P: pyridoxal phosphate binding domain), \[Red.\] = reduction, \[Ox.\] = oxidation. The proposed mechanism for FsqB-mediated isoquinoline formation is based on functional similarity to plant BBE^[@R17]--[@R19]^, see [Fig. 5](#F5){ref-type="fig"} for details. The role of the ATP-grasp enzyme FsqD in activating tyrosine to form **19** is putative.](nihms762624f3){#F3}

![The fumisoquins incorporate L-serine, L-tyrosine, and an L-methionine-derived methyl group\
Shown are HPLC-MS ion chromatograms derived from fungal cultures grown with (**a**) L-serine or L-\[^13^C~3~,^15^N\]-serine, (**b**) L-tyrosine or L-\[2-^13^C\]-tyrosine and (**c**) L-methionine or L-\[1′-^13^C\]-methionine. In contrast, L-cysteine is not incorporated ([Supplemental Fig. 6](#SD1){ref-type="supplementary-material"}). See [Supplementary Fig. 7](#SD1){ref-type="supplementary-material"} for mass spectra. (~\*~) denotes labeled isotopes. In the case of L-\[^13^C~3~,^15^N\]-serine, loss of ^15^N due to partial deamination/amination contributes to increased m/z = 362.](nihms762624f4){#F4}

![Enzymatic activity of recombinant FsqB\
(**a**) Synthesis of *N*-methyl-3′,4′-dihydroxy-DL-phenylalanine **11** (top) and regioselective conversion of **11** into **12** by purified recombinant FsqB (bottom). The isomer **13** does not form. (**b**) Ion chromatograms at indicated timepoints for the FsqB-catalyzed *in vitro* conversion of **11** to **12** (100 mM phoshate buffer, pH 7, 100:1 substrate to enzyme). (**c**) ^1^H NMR spectra of a sample of **11** (1 mM phosphate buffer in D~2~O) prior to FsqB addition (top) and 1 h post FsqB addition (333:1 substrate to enzyme), showing selective conversion of **11** into **12** (bottom) (**d**) Ion chromatograms showing formation of tyrosine and **16** as a result of capture of intermediate **17** by H~2~O or dimedone, **15** (1.5 μM FsqB and 400 μM *N*-methyl-L-tyrosine in 100 mM phoshate buffer, pH 7).](nihms762624f5){#F5}
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